Steve Tallant
Recent Posts
The European Union Intellectual Property Office (EUIPO) has just released a comprehensive report on counterfeiting and Intellectual Property Rights (IPR) infringement in the European Union.
The EU Falsified Medicines Directive (FMD) deadlines are now live. It is now time to reflect on this massive undertaking, and look at some “lessons learned”. We say this, because we are hearing grumblings in the field that serialization implementation projects are still ongoing. Additionally, the data integration requirements require live data connectivity to repositories like the EU Hub. Finally, when companies create new packaging lines, they will need to be equipped for serialization –...
GAMP, also known as Good Automated Manufacturing Practice (GAMP) is both a technical subcommittee of the International Society for Pharmaceutical Engineering (ISPE) and a set of guidelines for manufacturers and users of automated systems in the pharmaceutical industry.
By Steve Tallant, Director, Product Management and Marketing
Until recently, counterfeit health and beauty products could not be verified as the actual product, or authenticated, quickly and cost-effectively. Unfortunately, counterfeiters have been able to obtain printing and imaging technologies that mimic the real thing. Furthermore, Internet-based distribution outlets have proliferated, and it is difficult to tell an e-retailer that sells legitimate products from one selling counterfeits.